< Back to situations

We’ll email you as it develops, and you can follow the whole thread from day one.

[SITUATION] · [ACTIVE]

2 clusters · 18 sources · 1 days · First seen · Last updated

Categories: BUSINESS · HEALTH

US talc litigation and women's product safety

Entities: Johnson & Johnson · Chris Seeger · Joaquin Duato · California jury · US federal courts

Overview

U.S. courts continue to hear large talc lawsuits alleging that asbestos in baby powder caused ovarian cancer and mesothelioma. A California jury awarded $966 million to a mesothelioma patient, and manufacturers have set aside billions for liability, prompting the removal of talc baby‑powder from U.S. and Canadian markets.

Researchers have highlighted tumor risks from injectable contraceptives, widening the debate over women’s product safety.

Johnson & Johnson announced a settlement estimated at $5.5 billion to resolve roughly 76,000 U.S. talc‑related claims. The deal covers about 99.75 % of outstanding claims and becomes final only if at least 95 % of claimants in federal or state courts accept it. An initial $3 billion payment is scheduled for 2027, with further payments in 2028; the total could rise above $7 billion depending on claimant participation. The company maintains the claims lack merit, while plaintiffs’ counsel described the settlement as fair.

The settlement aims to end a decade‑long legal battle over alleged ovarian‑cancer links, though J&J continues to deny wrongdoing.

Claims

What the coverage asserts, and how well corroborated each claim is across sources.

Timeline

  1. 1 day ago

    [BUSINESS] 17 sources FAST-MOVING
    Johnson & Johnson to Pay $5.5 B to Settle U.S. Talc Cancer Lawsuits

    Johnson & Johnson will pay about $5.5 billion to settle 76,000 U.S. talc lawsuits, pending 95% claimant approval; total payout may exceed $7 billion.

  2. 1 day ago

    [HEALTH] 2 sources
    US Talc Lawsuits and Birth‑Control Risks Highlight Women's Product Safety

    US courts award $966 million in a talc baby‑powder case and highlight ongoing lawsuits, while studies link injectable birth‑control to meningioma risk, prompting calls for stricter product safety.

Sources

brasil.elpais.com · ct24.cz · dnyuz.com · gamereactor.de · gamereactor.no · gamereactor.pl · gamereactor.se · internewscast.com · muzejrudarstvaimetalurgije.org · n1info.hr · ndmais.com.br · nenoticias.com.br · newswire.lk · nypost.com · sapo.pt · thecurrent.pk · thefrontierpost.com · usanews.net

This summary has been updated 1 time: see revision history